Guangzhou LBP Medicine Science & Technology (688393.SH): Net profit for the year 2024 was 22.0369 million yuan, a year-on-year decrease of 44.99%.
Anbipelang (688393.SH) released its 2024 annual performance report announcement, reporting that the company achieved operating income...
Guangzhou LBP Medicine Science & Technology (688393.SH) released the performance report for the year 2024, during which the company achieved operating income of 471 million yuan, a decrease of 5.33% compared to the previous year; the net profit attributable to shareholders of the listed company was 22.0369 million yuan, a decrease of 44.99% year-on-year; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 13.7024 million yuan, a decrease of 61.20% year-on-year; and the basic earnings per share was 0.24 yuan/share.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


